Share on LinkedInShare on LinkedIn

ARTICLE · 04 DECEMBER 2017

Extrinsic Evidence Makes A "Swell" Difference In Claim Construction

Rohm & Haas owns two patents directed to a process for preparing emulsion polymers that can be used in opaque coatings, such as paints and inks.

United StatesIntellectual Property

Upholding a Patent Trial and Appeal Board (PTAB or Board) patentability finding, the US Court of Appeals for the Federal Circuit found that the PTAB did not err in determining the broadest reasonable construction of a claim term and finding that the record did not establish anticipation or obviousness. Organik Kimya AS v. Rohm & Haas Co., Case Nos. 15-1983; -2001 (Fed. Cir., Oct. 11, 2017) (Newman, J). 

Rohm & Haas owns two patents directed to a process for preparing emulsion polymers that can be used in opaque coatings, such as paints and inks. The opacity of the emulsion polymers is a property produced by voids formed within the polymer particles during the process. The claimed process requires the step of providing a monomer and a "swelling agent under conditions wherein there is no substantial polymerization of the monomer." Organik Kimya filed petitions for inter partes review against both patents, each of which was instituted. During the trial, the PTAB

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from